| Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells KH Liang, HC Tso, SH Hung, II Kuan, JK Lai, FY Ke, YT Chuang, IJ Liu, ... Cancer letters 433, 165-175, 2018 | 74 | 2018 |
| EpCAM signaling promotes tumor progression and protein stability of PD-L1 through the EGFR pathway HN Chen, KH Liang, JK Lai, CH Lan, MY Liao, SH Hung, YT Chuang, ... Cancer research 80 (22), 5035-5050, 2020 | 46 | 2020 |
| The hippo pathway in cardiac regeneration and homeostasis: new perspectives for cell-free therapy in the injured heart M Zheng, J Jacob, SH Hung, J Wang Biomolecules 10 (7), 1024, 2020 | 28 | 2020 |
| The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy A Chaudhri, X Bu, Y Wang, M Gomez, JA Torchia, P Hua, SH Hung, ... Frontiers in immunology 14, 1237715, 2023 | 8 | 2023 |
| The molecular mechanisms of EpCAM in regulating tumor progression in colon cancer cells KH Liang, HC Tso, SH Hung, MY Liao, HC Wu Cancer Research 79 (13_Supplement), 4670-4670, 2019 | 2 | 2019 |
| Abstract PO-061: Utilizing T cell receptor-based therapy to treat anaplastic thyroid cancer SH Hung, Y Henderson, K Pan, Y Chiu, S Singh, Y Chen, S Lai, C Yee Clinical Cancer Research 29 (18_Supplement), PO-061-PO-061, 2023 | 1 | 2023 |
| Modulating T cell metabolism to improve T cell therapy Y Li, SH Hung, S Singh, C Yee T Cell Metabolism and Cancer Immunotherapy, 1-24, 2025 | | 2025 |
| BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic Mechanism C Yee, K Saxena, E Ryu, SH Hung, S Singh, Q Zhang, Z Zeng, Z Wang, ... | | 2024 |
| Utilizing T cell receptor-based therapy to treat anaplastic thyroid cancer SH Hung, YC Henderson, P Ke, Y Chiu, S Singh, Y Chen, SY Lai, C Yee Cancer Research 84 (6_Supplement), 24-24, 2024 | | 2024 |
| 808 The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy A Chaudhri, X Bu, Y Wang, P Hua, SH Hung, MA Davies, GA Lizee, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 229 CX3CR1 in exhausted CD8 T cell states A Chaudhri, Y Wang, SH Hung, G Lizee, U Von Andrian, P Hwu, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A244-A244, 2021 | | 2021 |
